Anticoagulation of women with congenital heart disease during pregnancy

Outcome of patients with congenital heart disease (CHD) has significantly improved over the last 40 years and most patients survive into adulthood. A considerable number of women with repaired and non-repaired CHD lesions reach the age of procreation. These patients encounter more frequently maternal and fetal complications during pregnancy than the general population. Pregnant patients with CHD are not only at a particularly elevated risk for...